Doctor profile · Federal record
Dr. Rodolfo Galindo, M.D
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Miami, FL
- NPI 1558532531
- Accepts Medicare
- 13 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1475 Nw 12Th Ave Fl 1
Miami, FL 331361002
(305) 243-3636
fax (305) 243-6575 - Mailing address
-
1400 Nw 10Th Ave Ste 805
Miami, FL 331361031
Credentials & registration
- NPI registered
- March 2008 — 18 yrs on file
- Profile last updated
- December 21, 2022
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Florida #ME158845
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558532531. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15
Distinct HCPCS
1
Medicare allowed
$2,064
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 15 | 11 | $138 |
In context: peer comparison
Among 14 peers in Miami Endocrinology, Diabetes & Metabolism Physician, average services per provider: 56. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$16,545
Transactions
31
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, INC. | 12 | $9,337.02 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $3,591.00 | |
| Dexcom, INC. | 1 | $1,327.50 | |
| Eli Lilly and Company | 3 | $1,198.43 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 6 | $691.72 | |
| Sanofi-Aventis U.S. LLC | 2 | $161.76 | |
| Lilly USA, LLC | 2 | $156.79 | |
| Novo Nordisk INC | 2 | $64.54 | |
| Abbott Laboratories | 1 | $16.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
269
Patients
22
Total drug cost
$187,210
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 32 | 0 | $29,119 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 25 | 0 | $35,162 |
| Atorvastatin Calcium | Generic | 23 | 11 | $415 |
| Mounjaro (Tirzepatide) | Brand | 22 | 0 | $24,409 |
| Jardiance (Empagliflozin) | Brand | 19 | 0 | $18,851 |
| Techlite Pen Needle (Pen Needle, Diabetic) | Brand | 18 | 11 | $439 |
| Tresiba Flextouch U-200 (Insulin Degludec) | Brand | 17 | 0 | $14,794 |
| Trulicity (Dulaglutide) | Brand | 17 | 0 | $28,934 |
| Januvia (Sitagliptin Phosphate) | Brand | 16 | 0 | $13,333 |
| Gabapentin | Generic | 15 | 0 | $566 |
Frequently asked questions
What is Dr. Rodolfo Galindo's medical specialty?
Dr. Rodolfo Galindo practices Endocrinology, Diabetes & Metabolism Physician in Miami, FL.
Where does Dr. Rodolfo Galindo practice?
Dr. Rodolfo Galindo practices at 1475 Nw 12Th Ave Fl 1, Miami, FL 331361002. Office phone: 3052433636.
What is Dr. Rodolfo Galindo's NPI?
Dr. Rodolfo Galindo's National Provider Identifier (NPI) is 1558532531, issued by NPPES.
Does Dr. Rodolfo Galindo accept Medicare assignment?
Yes. Dr. Rodolfo Galindo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rodolfo Galindo commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.